IN8bio, Inc.

As of June 11, 2025, the technical trend has shifted to a bearish stance with moderate strength, driven by negative indicators like a bearish MACD and moving averages, despite some bullish signals from the RSI.

IN8bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $6 million and a market cap of $7.37 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -211.64%.

As of Jun 18, IN8bio, Inc. has a market capitalization of 7.37 million, with net sales of 0.00 million and a net profit of -27.43 million over the last four quarters. The company reported shareholder's funds of 14.48 million and total assets of 21.99 million as of Dec 24.